Comparative Risk of Serious Infections With Biologic and/or Immunosuppressive Therapy in Patients with Inflammatory Bowel Diseases: a Systematic Review and Meta-analysis

Inflammatory Bowel Disease

Systematic Review with Meta-analysis: The Impact of Co-occurring Immune-mediated Inflammatory Diseases on the Disease Course of Inflammatory Bowel Diseases

Inflamm Bowel Dis.

Attauabi M, Zhao M, Bendtsen F, Burisch J

doi: 10.1093/ibd/izaa167.

Inflammatory Bowel Disease

Risk of Postoperative Infectious Complications From Medical Therapies in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

Inflamm Bowel Dis.

Law CCY, Koh D, Bao Y, Jairath V, Narula N

doi: 10.1093/ibd/izaa020.

Inflammatory Bowel Disease

The risk of rheumatoid arthritis among patients with inflammatory bowel disease: a systematic review and meta-analysis

BMC Gastroenterol.

Chen Y, Chen L, Xing C, Deng G, Zeng F, Xie T, Gu L, Yang H

doi: 10.1186/s12876-020-01339-3.

Inflammatory Bowel Disease

Risk and outcomes of coronavirus disease (COVID-19) in patients with inflammatory bowel disease: a systematic review and meta-analysis

United European Gastroenterol J

Singh AK, Jena A, Kumar-M P, Sharma V, Sebastian S

doi: 10.1177/2050640620972602

Inflammatory Bowel Disease

Real-world Pattern of Biologic Use in Patients With Inflammatory Bowel Disease: Treatment Persistence, Switching, and Importance of Concurrent Immunosuppressive Therapy

Inflamm Bowel Dis.

Chen C, Hartzema AG, Xiao H, Wei YJ, Chaudhry N, Ewelukwa O, Glover SC, Zimmermann EM

doi: 10.1093/ibd/izz001.

RECOMMENDED

Inflammatory Bowel Disease

Early vs Late Use of Anti-TNFa Therapy in Adult Patients With Crohn Disease: A Systematic Review and Meta-Analysis

★ 2 Recommended by Prof. Dr Stephan Vavricka, Faculty Member

Inflamm Bowel Dis.

Hamdeh S, Aziz M, Altayar O, Olyaee M, Murad MH, Hanauer SB

doi: 10.1093/ibd/izaa031.

Inflammatory Bowel Disease

A Systematic Review on Cost-effectiveness Analyses of Therapeutic Drug Monitoring for Patients with Inflammatory Bowel Disease: From Immunosuppressive to Anti-TNF Therapy

Inflamm Bowel Dis.

Yao J, Jiang X, You JHS

doi: 10.1093/ibd/izaa073.

Inflammatory Bowel Disease

Vitamin D Therapy in Adults With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

Inflamm Bowel Dis.

Guzman-Prado Y, Samson O, Segal JP, Limdi JK, Hayee B

doi: 10.1093/ibd/izaa087.

Inflammatory Bowel Disease

Pre-treatment Frailty Is Independently Associated With Increased Risk of Infections After Immunosuppression in Patients with Inflammatory Bowel Diseases

Gastroenterology.

Kochar B, Cai W, Cagan A, Ananthakrishnan AN

doi: 10.1053/j.gastro.2020.02.032.

Related content

Systematic Review with Meta-analysis: The Impact of Co-occurring Immune-mediated Inflammatory Diseases on the Disease Course of Inflammatory Bowel Diseases

Risk of Postoperative Infectious Complications From Medical Therapies in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

The risk of rheumatoid arthritis among patients with inflammatory bowel disease: a systematic review and meta-analysis

Risk and outcomes of coronavirus disease (COVID-19) in patients with inflammatory bowel disease: a systematic review and meta-analysis

Real-world Pattern of Biologic Use in Patients With Inflammatory Bowel Disease: Treatment Persistence, Switching, and Importance of Concurrent Immunosuppressive Therapy

Early vs Late Use of Anti-TNFa Therapy in Adult Patients With Crohn Disease: A Systematic Review and Meta-Analysis

A Systematic Review on Cost-effectiveness Analyses of Therapeutic Drug Monitoring for Patients with Inflammatory Bowel Disease: From Immunosuppressive to Anti-TNF Therapy

Vitamin D Therapy in Adults With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

Pre-treatment Frailty Is Independently Associated With Increased Risk of Infections After Immunosuppression in Patients with Inflammatory Bowel Diseases